Adamis Pharmaceuticals Corp (ADMP): should hopefully be back into the .50&#3...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	20
Posts	1888
Boards Moderated	0
Alias Born	03/04/2009

idowonder

Re: None

Thursday, 01/13/2022 11:49:49 AM

Thursday, January 13, 2022 11:49:49 AM

should hopefully be back into the .50's soon, got some today at .63 will await the .50's for next buy.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADMP News

Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:50:07 PM
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus • GlobeNewswire Inc. • 09/07/2023 04:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:45:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:30:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 09:20:33 PM
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/21/2023 01:15:00 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:38:44 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 08/10/2023 08:03:30 PM
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering • GlobeNewswire Inc. • 08/04/2023 05:43:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:59:45 PM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/03/2023 08:55:39 PM
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering • GlobeNewswire Inc. • 08/02/2023 12:30:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/02/2023 04:15:27 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:13:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2023 09:01:12 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/28/2023 08:58:05 PM
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert • GlobeNewswire Inc. • 07/28/2023 12:30:00 PM
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/27/2023 10:08:01 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/27/2023 01:17:09 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:20:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:15:12 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/13/2023 08:37:24 PM
Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 06/26/2023 11:30:00 AM

More ADMP News

InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover